Although we did not observe differences in the E-cadherin level between patient groups, KS/HIV patients had a two-fold higher median value of E-cadherin level than HIV+ asymptomatic patients (1029.7 vs. 447.9, respectively) at baseline, and it was maintained at W4. Here, CDH1 is linked to Kaposi's sarcoma.